Voloridge Investment Management, LLC Intellia Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

A detailed history of Voloridge Investment Management, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 467,243 shares of NTLA stock, worth $5.14 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

467,243

Previous 452,448 3.27%

Holding current value

$5.14 Million

Previous $10.1 Million 5.18%

% of portfolio

0.04%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$19.72 - $27.36 $291,757 - $404,791	14,795 Added 3.27%	467,243 $9.6 Million
Q2 2024 Aug 14, 2024	SELL	$20.02 - $27.22 $6.87 Million - $9.34 Million	-343,066 Reduced 43.13%	452,448 $10.1 Million
Q1 2024 May 15, 2024	BUY	$23.82 - $32.8 $18.2 Million - $25 Million	762,258 Added 2292.09%	795,514 $21.9 Million
Q4 2023 Feb 14, 2024	BUY	$23.16 - $32.34 $770,208 - $1.08 Million	33,256 New	33,256 $1.01 Million
Q2 2023 Aug 14, 2023	SELL	$34.58 - $46.03 $380,241 - $506,145	-10,996 Reduced 13.18%	72,443 $2.95 Million
Q1 2023 May 15, 2023	BUY	$33.3 - $44.82 $2.04 Million - $2.74 Million	61,201 Added 275.21%	83,439 $3.11 Million
Q4 2022 Feb 14, 2023	BUY	$33.21 - $62.69 $738,523 - $1.39 Million	22,238 New	22,238 $775,000
Q2 2022 Aug 15, 2022	BUY	$38.49 - $76.21 $1.15 Million - $2.28 Million	29,871 Added 42.97%	99,379 $5.14 Million
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $1.11 Million - $2.26 Million	19,023 Added 37.68%	69,508 $5.05 Million
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $17.9 Million - $24.6 Million	-177,536 Reduced 77.86%	50,485 $5.97 Million
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $16.5 Million - $22 Million	124,418 Added 120.09%	228,021 $30.6 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $6.31 Million - $16.8 Million	103,603 New	103,603 $16.8 Million
Q1 2021 May 17, 2021	SELL	$46.59 - $83.68 $226,800 - $407,354	-4,868 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$18.83 - $63.53 $387,370 - $1.31 Million	-20,572 Reduced 80.86%	4,868 $265,000
Q3 2020 Nov 16, 2020	BUY	$17.47 - $24.93 $444,436 - $634,219	25,440 New	25,440 $506,000
Q1 2020 May 15, 2020	SELL	$9.44 - $15.58 $192,406 - $317,551	-20,382 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$10.43 - $17.67 $212,584 - $360,149	20,382 New	20,382 $299,000
Q3 2019 Nov 14, 2019	SELL	$13.07 - $18.51 $430,212 - $609,275	-32,916 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$13.88 - $18.41 $456,874 - $605,983	32,916 New	32,916 $539,000

Others Institutions Holding NTLA

# of Institutions

317

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $835M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Intellia Therapeutics, Inc. Transaction History